Pulmozyme and Pregnancy

Animal studies on Pulmozyme and pregnancy did not show any problems in the fetus. As a result, the FDA assigned a pregnancy Category B rating to the drug. However, since animals and humans do not always respond to drugs in the same way, if you are taking Pulmozyme and pregnancy occurs, your healthcare provider will consider the benefits and risks in your particular situation.

Pulmozyme Drug Information

Is Pulmozyme Safe During Pregnancy?

Pulmozyme^® (dornase alfa) is a prescription medication used to treat cystic fibrosis. It is probably safe for use in pregnant women. In animal studies that looked at the effects of Pulmozyme during pregnancy, the drug did not appear to cause any problems.

Pulmozyme and Pregnancy Category B

The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is given to medicines that have not been studied in pregnant humans but that do not appear to cause harm to the fetus in animal studies.

However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if the healthcare provider believes that the benefits to the woman outweigh any risks to the unborn child.

Pulmozyme and Pregnancy: Final Thoughts

If you are pregnant or are thinking of becoming pregnant while taking Pulmozyme, let your healthcare provider know. He or she will consider both the benefits and risks of taking the drug during pregnancy before making a recommendation in your particular situation.